458 filings
Page 3 of 23
SC 13G/A
PWCCF
Power Corp of Canada
23 Jan 23
BELLUS Health / Power Corp of Canada ownership change
3:28pm
6-K
BLU
Bellus Health Inc
14 Nov 22
Condensed Consolidated Interim Financial Statements of
5:26pm
SUPPL
BLU
Bellus Health Inc
14 Nov 22
Supplemental materials (foreign)
5:25pm
6-K
BLU
Bellus Health Inc
14 Nov 22
Open Market Sale Agreementsm
5:19pm
6-K
BLU
Bellus Health Inc
14 Nov 22
BELLUS Health Reports Third Quarter 2022 Financial Results and Business Highlights
4:03pm
6-K
BLU
Bellus Health Inc
10 Nov 22
BELLUS Health to Participate in Two Upcoming Healthcare Investor Conferences
4:01pm
6-K
BLU
Bellus Health Inc
11 Oct 22
BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting
7:00am
6-K
BLU
Bellus Health Inc
16 Sep 22
Investor Presentation NASDAQ/TSX - BLU September 16 th , 2022
4:40pm
6-K
BLU
Bellus Health Inc
6 Sep 22
BELLUS Health to Present at the H.C. Wainwright Global Investment Conference
7:00am
F-X
BLU
Bellus Health Inc
26 Aug 22
Appointment of agent for service of process by issuers registering securities
5:02pm
F-10
BLU
Bellus Health Inc
26 Aug 22
Registration of securities (Canada)
4:48pm
6-K
BLU
Bellus Health Inc
10 Aug 22
Condensed Consolidated Interim Financial Statements of
4:56pm
6-K
BLU
Bellus Health Inc
10 Aug 22
BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
4:31pm
6-K
BLU
Bellus Health Inc
18 Jul 22
BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States
4:05pm
SUPPL
BLU
Bellus Health Inc
15 Jul 22
Supplemental materials (foreign)
7:01am
6-K
BLU
Bellus Health Inc
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
SUPPL
BLU
Bellus Health Inc
13 Jul 22
Supplemental materials (foreign)
5:01pm
6-K
BLU
Bellus Health Inc
13 Jul 22
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
4:25pm
6-K
BLU
Bellus Health Inc
13 Jul 22
Current report (foreign)
4:10pm
6-K
BLU
Bellus Health Inc
12 Jul 22
Bellus Health Announces Positive End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough
7:27am